中西医结合临床诊疗乳腺增生专家共识  

Expert consensus on clinical diagnosis and treatment of breast hyperplasia with integrated traditional Chinese and Western medicine

作　　者：世界中医药学会联合会乳腺病专业委员会 刘胜 王怡[3] 吴春宇 陈佳静[3] Breast Disease Professional Committee of World Federation of Chinese Medicine;LIU Sheng;WANG Yi;WU Chun-yu;CHEN Jia-jing(不详;Graduate School of Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of Breast of Integrated Traditional Chinese and Western Medicine,Longhua Hospital Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China)

机构地区：[1]不详 [2]上海中医药大学研究生院,上海201203 [3]上海中医药大学附属龙华医院中西医结合乳腺科,上海200032

出　　处：《中华中医药杂志》2023年第3期1159-1164,共6页China Journal of Traditional Chinese Medicine and Pharmacy

基　　金：上海市2020年度“科技创新行动计划”(No.20Z21900300)。

摘　　要：乳腺增生是乳腺疾病中发病率最高的良性疾病,以青中年女性群体为主。目前治疗该疾病手段众多,中医药及西药在缓解症状和体征方面均起到了一定作用,但尚缺乏中西医结合诊疗的共识。世界中医药学会联合会乳腺病专业委员会对该疾病的病名进行了统一,并梳理了疾病的诊断标准。在以往中西医药物治疗的基础上对手术介入的时间进行了规范,并推荐了相应的辅助治疗。本共识首次增加了主客观疗效评价标准。最终经过3轮专家投票,形成中西医结合临床诊疗乳腺增生专家共识。Breast hyperplasia is a benign disease with the highest incidence of breast diseases,mainly in young and middle-aged women.However,there are many treatment methods for this disease.Integrative Chinese and Western medicine have played a certain role in alleviating symptoms,but there is still lack of consensus on this.The Breast Diseases Professional Committee of World Federation of Chinese Medicine has unified the name of the disease and sorted out the diagnostic criteria of the disease.On the basis of traditional Chinese and Western medicine treatment,the time of surgical intervention was standardized,and the corresponding adjuvant treatment was recommended.This consensus adds subjective and objective efficacy evaluation criteria for the first time.Finally,after three rounds of expert voting,an expert consensus on the clinical diagnosis and treatment of breast hyperplasia with integrated traditional Chinese and Western medicine was formed.

关 键 词：乳腺增生 专家共识 诊断 中西医结合治疗 评价体系 

分 类 号：R655.8[医药卫生—外科学]